Ethanolamine oleate
Ethamolin (ethanolamine oleate) is a small molecule pharmaceutical. Ethanolamine oleate was first approved as Ethamolin on 1988-12-22. It is used to treat esophageal and gastric varices in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| digestive system diseases | D004066 |
Trade Name
FDA
EMA
Ethamolin
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ethanolamine oleate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ETHAMOLIN | Qol Medical | N-019357 RX | 1988-12-22 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| ethamolin | New Drug Application | 2021-02-09 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| esophageal and gastric varices | EFO_0009545 | D004932 | I85 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
Code | Description |
|---|---|
| J1430 | Injection, ethanolamine oleate, 100 mg |
Clinical
Clinical Trials
4 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sleep initiation and maintenance disorders | D007319 | F51.01 | — | — | 1 | 2 | 1 | 4 | |
| Renal dialysis | D006435 | EFO_0010690 | Z99.2 | — | — | — | 1 | — | 1 |
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chinese traditional medicine | D008516 | — | — | — | — | 1 | 1 | ||
| Circadian rhythm | D002940 | EFO_0004354 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | ETHANOLAMINE OLEATE |
| INN | monoethanolamine oleate |
| Description | Ethanolamine is a member of the class of ethanolamines that is ethane with an amino substituent at C-1 and a hydroxy substituent at C-2, making it both a primary amine and a primary alcohol. It has a role as a human metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a primary amine, a primary alcohol and a member of ethanolamines. It is a conjugate base of an ethanolaminium(1+). |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CCCCCCCC/C=C\CCCCCCCC(=O)O.NCCO |
Identifiers
| PDB | — |
| CAS-ID | 141-43-5 |
| RxCUI | 24457 |
| ChEMBL ID | CHEMBL3989529 |
| ChEBI ID | — |
| PubChem CID | 700 |
| DrugBank | DB06689 |
| UNII ID | U4RY8MRX7C (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 655 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
479 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more